Search results for "Coronavirus"
New authorization, guidance on vaccines against SARS-CoV-2
The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020
Latest data on COVID-19's potential treatments, effects on drug abuse and mortality
A living systematic review still only finds strong support for steroids, an antibody cocktail reduced viral load in outpatients, overdoses rose during lockdowns, and studies looked at loss of life from the pandemic.
https://immattersacp.org/weekly/archives/2020/12/22/2.htm
22 Dec 2020
Still time to register for COVID-19 Vaccine Forum II—Promoting COVID-19 Vaccination: What Physicians Need to Know
The virtual live event hosted by ACP and Annals of Internal Medicine on Wednesday, Dec. 16, will provide unique insight and practical information from a panel of experts on promoting COVID-19 vaccination confidence and uptake.
https://immattersacp.org/weekly/archives/2020/12/15/2.htm
15 Dec 2020
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
COVID-19 Vaccine Forum II—Promoting COVID-19 Vaccination: What Physicians Need to Know
The virtual live event hosted by ACP and Annals of Internal Medicine on Dec. 16 will provide unique insight and practical information from a panel of experts on promoting COVID-19 vaccination confidence and uptake.
https://immattersacp.org/weekly/archives/2020/12/08/2.htm
8 Dec 2020
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020
ACP PPE sale offers gloves, N95 respirators, masks, and more
ACP members can buy personal protective equipment (PPE) at a low cost through a limited-time offer starting Nov. 30.
https://immattersacp.org/weekly/archives/2020/11/24/2.htm
24 Nov 2020
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
COVID-19 news on monoclonal antibodies, psychiatric drug and complications
A monoclonal antibody received emergency use authorization, but experts described implementation challenges with this therapeutic class. New research found potential benefit from a psychiatric drug in COVID-19 outpatients and associations of COVID-19 with psychiatric disorders.
https://immattersacp.org/weekly/archives/2020/11/17/1.htm
17 Nov 2020
Guidance on using rapid tests, managing COPD, and screening for cardiac problems in COVID-19
The FDA warned about false positives with rapid tests, guidance addressed care for chronic obstructive pulmonary disease (COPD) during the pandemic, and experts advised on ethics of emergency use authorizations, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2020/11/10/1.htm
10 Nov 2020